{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:32:05Z","timestamp":1785789125810,"version":"3.56.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1097\/01.jcp.0000104912.75206.2b","type":"journal-article","created":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T23:51:48Z","timestamp":1094082708000},"page":"83-86","source":"Crossref","is-referenced-by-count":53,"title":["The Effect of Vitamin E Treatment on Tardive Dyskinesia and Blood Superoxide Dismutase"],"prefix":"10.1097","volume":"24","author":[{"given":"Xiang Yang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian Yuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1749-6632.1989.tb14918.x","article-title":"Possible involvement of free radicals in neuroleptic-induced movement disorders: evidence from treatment of tardive dyskinesia with vitamin E.","volume":"570","author":"Cadet","year":"1989","journal-title":"Ann NY Acad Sci"},{"key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.1991.01810360061009","article-title":"Oxygen radicals and neuropsychiatric illness. Some speculations.","volume":"48","author":"Lohr","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"R3-14-20210128","first-page":"159","article-title":"Free radical involvement in neuropsychiatric illnesses.","volume":"31","author":"Lohr","year":"1995","journal-title":"Psychopharmacol Bull"},{"key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1176\/ajp.155.9.1207","article-title":"Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia.","volume":"155","author":"Tsai","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0006-3223(90)90490-S","article-title":"Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia.","volume":"28","author":"Lohr","year":"1990","journal-title":"Biol Psychiatry"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0952-3278(96)90149-0","article-title":"Antioxidant treatment of tardive dyskinesia.","volume":"55","author":"Rotrosen","year":"1996","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/oxfordjournals.schbul.a033414","article-title":"Tardive dyskinesia: possible involvement of free radicals.","volume":"25","author":"Elkashef","year":"1999","journal-title":"Schizophr Bull"},{"key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(87)92878-9","article-title":"Alpha-tocopherol in tardive dyskinesia.","volume":"1","author":"Lohr","year":"1987","journal-title":"Lancet"},{"key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1176\/ajp.149.6.773","article-title":"Treatment of tardive dyskinesia with vitamin E.","volume":"149","author":"Egan","year":"1992","journal-title":"Am J Psychiatry"},{"key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1176\/ajp.150.9.1405","article-title":"Vitamin E treatment of tardive dyskinesia.","volume":"150","author":"Adler","year":"1993","journal-title":"Am J Psychiatry"},{"key":"R11-14-20210128","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0006-3223(97)00027-9","article-title":"Long-term treatment effects of vitamin E for tardive dyskinesia.","volume":"43","author":"Adler","year":"1998","journal-title":"Biol Psychiatry"},{"key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10401239809148942","article-title":"Vitamin E in the treatment of tardive dyskinesia: a statistical meta-analysis.","volume":"10","author":"Barak","year":"1998","journal-title":"Ann Clin Psychiatry"},{"key":"R13-14-20210128","first-page":"167","article-title":"A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.","volume":"57","author":"Lohr","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archpsyc.56.9.836","article-title":"Vitamin E treatment for tardive dyskinesia.","volume":"56","author":"Adler","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1017\/S0033291797005114","article-title":"Low superoxide dismutase activity in schizophrenic patients with tardive dyskinesia.","volume":"27","author":"Yamada","year":"1997","journal-title":"Psychol Med"},{"key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/10401239709147773","article-title":"Tardive dyskinesia and ethnicity: review of the literature.","volume":"9","author":"Swartz","year":"1997","journal-title":"Ann Clin Psychiatry"},{"key":"R17-14-20210128","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1982.04290040080014","article-title":"Research diagnoses for tardive dyskinesia.","volume":"39","author":"Schooler","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00004714-200102000-00015","article-title":"The effect of extract of ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia.","volume":"21","author":"Zhang","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R20-14-20210128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/schbul\/14.2.291","article-title":"Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms.","volume":"14","author":"Lohr","year":"1988","journal-title":"Schizophr Bull"},{"key":"R21-14-20210128","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0006-8993(97)00041-3","article-title":"Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia.","volume":"754","author":"Wengenack","year":"1997","journal-title":"Brain Res"},{"key":"R22-14-20210128","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(97)01469-8","article-title":"Effects of over- and under-expression of Cu, Zn-superoxide dismutase on the toxicity of glutamate analogs in transgenic mouse striatum.","volume":"789","author":"Schwarts","year":"1998","journal-title":"Brain Res"},{"key":"R23-14-20210128","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.1994.tb12073.x","article-title":"()Deprenyl increases the life span as well as activities of superoxide dismutase and catalase but not of glutathione peroxidase in selective brain regions in Fischer rats.","volume":"717","author":"Kitani","year":"1994","journal-title":"Ann N Y Acad Sci"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.jcp.0000104912.75206.2b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:40:35Z","timestamp":1785786035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200402000-00014"}},"subtitle":["A Double-Blind Placebo-Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jcp.0000104912.75206.2b","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}